Hideaki Minoura
Astellas Pharma (Japan)(JP)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Diabetes Treatment and Management, Peroxisome Proliferator-Activated Receptors, Pancreatic function and diabetes
Most-Cited Works
- → Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase(1999)394 cited
- → Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614(2004)79 cited
- → Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion(2013)40 cited
- → Mechanism by which a novel non‐thiazolidinedione peroxisome proliferator‐activated receptor γ agonist, FK614, ameliorates insulin resistance in Zucker fatty rats(2006)36 cited
- → Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor γ agonist, on insulin resistance in Zucker fatty rat(2005)34 cited
- → Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion(2013)28 cited
- → The Sodium Glucose Cotransporter 2 Inhibitor Ipragliflozin Promotes Preferential Loss of Fat Mass in Non-obese Diabetic Goto–Kakizaki Rats(2017)10 cited
- → Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy(2001)6 cited
- → FK352: A NOVEL. WATER-SOLUBLE. A1-SELECTIVE. ADENOSINE ANTAGONIST(1995)2 cited
- → Pharmacological and clinical profile of nitisinone (Orfadin<sup>®</sup> Capsules): a therapeutic agent for hereditary tyrosinemia type 1(2015)1 cited